Clare Cutri-French1, Dallas Armstrong2, Joni Saby3, Casey Gorman2, Jane Lane4, Cary Fu5, Sarika U Peters5, Alan Percy5, Jeffrey L Neul2, Eric D Marsh1,2. 1. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 2. Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 3. Division of Radiology Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 4. Department of Pediatrics, Civitan International Research Center, University of Alabama at Birmingham, Birmingham, Alabama. 5. Department of Pediatrics, Vanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
OBJECTIVE: Rett syndrome, CDKL5-deficiency disorder, FOXG1 disorder, and MECP2 duplication disorder are developmental encephalopathies with shared and distinct features. Although they are historically linked, no direct comparison has been performed. The first head-to-head comparison of clinical features in these conditions is presented. METHODS: Comprehensive clinical information was collected from 793 individuals enrolled in the Rett and Rett-Related Disorders Natural History Study. Clinical features including clinical severity, regression, and seizures were cross-sectionally compared between diagnoses to test the hypothesis that these are 4 distinct disorders. RESULTS: Distinct patterns of clinical severity, seizure onset age, and regression were present. Individuals with CDKL5-deficency disorder were the most severely affected and had the youngest age at seizure onset (2 months), whereas children with MECP2 duplication syndrome had the oldest median age at seizure onset (64 months) and lowest severity scores. Rett syndrome and FOGX1 were intermediate in both features. Smaller head circumference correlates with increased severity in all disorders and earlier age at seizure onset in MECP2 duplication syndrome. Developmental regression occurred in all Rett syndrome participants (median = 18 months) but only 23 to 34% of the other disorders. Seizure incidence prior to the baseline visit was highest for CDKL5 deficiency disorder (96.2%) and lowest for Rett syndrome (47.5%). Other clinical features including seizure types and frequency differed among groups. INTERPRETATION: Although these developmental encephalopathies share many clinical features, clear differences in severity, regression, and seizures warrant considering them as unique disorders. These results will aid in the development of disease-specific severity scales, precise therapeutics, and future clinical trials. ANN NEUROL 2020;88:396-406.
OBJECTIVE: Rett syndrome, CDKL5-deficiency disorder, FOXG1 disorder, and MECP2 duplication disorder are developmental encephalopathies with shared and distinct features. Although they are historically linked, no direct comparison has been performed. The first head-to-head comparison of clinical features in these conditions is presented. METHODS: Comprehensive clinical information was collected from 793 individuals enrolled in the Rett and Rett-Related Disorders Natural History Study. Clinical features including clinical severity, regression, and seizures were cross-sectionally compared between diagnoses to test the hypothesis that these are 4 distinct disorders. RESULTS: Distinct patterns of clinical severity, seizure onset age, and regression were present. Individuals with CDKL5-deficency disorder were the most severely affected and had the youngest age at seizure onset (2 months), whereas children with MECP2 duplication syndrome had the oldest median age at seizure onset (64 months) and lowest severity scores. Rett syndrome and FOGX1 were intermediate in both features. Smaller head circumference correlates with increased severity in all disorders and earlier age at seizure onset in MECP2 duplication syndrome. Developmental regression occurred in all Rett syndrome participants (median = 18 months) but only 23 to 34% of the other disorders. Seizure incidence prior to the baseline visit was highest for CDKL5 deficiency disorder (96.2%) and lowest for Rett syndrome (47.5%). Other clinical features including seizure types and frequency differed among groups. INTERPRETATION: Although these developmental encephalopathies share many clinical features, clear differences in severity, regression, and seizures warrant considering them as unique disorders. These results will aid in the development of disease-specific severity scales, precise therapeutics, and future clinical trials. ANN NEUROL 2020;88:396-406.
Authors: Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke Journal: Pediatr Neurol Date: 2019-02-23 Impact factor: 3.372
Authors: Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das Journal: Pediatr Neurol Date: 2013-05 Impact factor: 3.372
Authors: Carolyn Schanen; Elisa J F Houwink; Naghmeh Dorrani; Jane Lane; Ruth Everett; Alice Feng; Rita M Cantor; Alan Percy Journal: Am J Med Genet A Date: 2004-04-15 Impact factor: 2.802
Authors: Mari Wold Henriksen; Hilde Breck; Stephen von Tetzchner; Benedicte Paus; Ola H Skjeldal; Eylert Brodtkorb Journal: Epilepsy Res Date: 2018-06-23 Impact factor: 3.045
Authors: William Hong; Isabel Haviland; Elia Pestana-Knight; Judith L Weisenberg; Scott Demarest; Eric D Marsh; Heather E Olson Journal: CNS Drugs Date: 2022-05-28 Impact factor: 6.497
Authors: Sam Amin; Marie Monaghan; Angel Aledo-Serrano; Nadia Bahi-Buisson; Richard F Chin; Angus J Clarke; J Helen Cross; Scott Demarest; Orrin Devinsky; Jenny Downs; Elia M Pestana Knight; Heather Olson; Carol-Anne Partridge; Graham Stuart; Marina Trivisano; Sameer Zuberi; Tim A Benke Journal: Front Neurol Date: 2022-06-20 Impact factor: 4.086
Authors: Heather E Olson; Carolyn I Daniels; Isabel Haviland; Timothy A Benke; Annapurna Poduri; Lindsay C Swanson; Caitlin A Greene; Anne Marie M Denny; Scott T Demarest; Elia Pestana-Knight; Xiaoming Zhang; Ahsan N Moosa; Andrea Fidell; Judith L Weisenberg; Bernhard Suter; Cary Fu; Jeffrey L Neul; Alan K Percy; Eric D Marsh Journal: J Neurodev Disord Date: 2021-09-16 Impact factor: 4.025
Authors: Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard Journal: Orphanet J Rare Dis Date: 2022-03-21 Impact factor: 4.123
Authors: Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul Journal: Am J Med Genet A Date: 2020-11-10 Impact factor: 2.802